DYNATRONICS CORP. is involved in the design, manufacture and sale of medical devices for therapeutic use by medical practitioners.
| Revenue (Most Recent Fiscal Year) | $27.39M |
| Net Income (Most Recent Fiscal Year) | $-10.90M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.01 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 0.04 |
| Pre-Tax Margin (Trailing 12 Months) | -39.99% |
| Net Margin (Trailing 12 Months) | -40.04% |
| Return on Equity (Trailing 12 Months) | -111.43% |
| Return on Assets (Trailing 12 Months) | -13.41% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.07 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.50 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 3.84 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-0.36 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.35 |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 16.05M |
| Free Float | 15.58M |
| Market Capitalization | $0.24M |
| Average Volume (Last 20 Days) | 0.06M |
| Beta (Past 60 Months) | 0.31 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 2.90% |
| Percentage Held By Institutions (Latest 13F Reports) | 4.18% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |